Page last updated: 2024-11-06

prednisolone and Wet Macular Degeneration

prednisolone has been researched along with Wet Macular Degeneration in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Wet Macular Degeneration: A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.

Research Excerpts

ExcerptRelevanceReference
"Treatment by prednisolone eye drops was initiated every 30 minutes for 1 day with a gradual decrease for 6 weeks."1.91Preventive Inflammation Management with Steroids before Retreatment with Anti-VEGF after Severe Inflammation due to Brolucizumab. ( Ambresin, A; Castro, DG; Karmy, BE, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Karmy, BE1
Castro, DG1
Ambresin, A1

Other Studies

1 other study available for prednisolone and Wet Macular Degeneration

ArticleYear
Preventive Inflammation Management with Steroids before Retreatment with Anti-VEGF after Severe Inflammation due to Brolucizumab.
    Klinische Monatsblatter fur Augenheilkunde, 2023, Volume: 240, Issue:4

    Topics: Aged, 80 and over; Angiogenesis Inhibitors; Female; Humans; Inflammation; Intravitreal Injections; M

2023